IthaID: 2190


Names and Sequences

Functionality: Globin gene causative mutation Pathogenicity: N/A
Common Name: CD 62-83 (+65 bp) HGVS Name: HBB:c.187_251dup
Hb Name: N/A Protein Info: N/A

Also known as:

Comments: The 65bp duplication first reported in a 30-year-old Ghanaian male and later in a 31-year-old African-Canadian female and her father. The duplication introduces a stop codon twenty-six amino acids further down the new reading frame leading to a truncated β chain of only 109 residues. In all 3 cases, the duplication found in association with the common δ globin variant Hb A2' [IthaID:1356] and all presented with Hb A2' variant and normal levels of HbA2. These findings support that the 65bp duplication and the δ globin variant Hb A2' are in cis.

We follow the HGVS sequence variant nomenclature and IUPAC standards.

Phenotype

Hemoglobinopathy Group: Thalassaemia
Hemoglobinopathy Subgroup: β-thalassaemia
Allele Phenotype:β0
Associated Phenotypes: Haemolytic anaemia [HP:0001878]
Ineffective erythropoiesis [HP:0010972]

Location

Chromosome: 11
Locus: NG_000007.3
Locus Location: 70911
Size: 65 bp
Located at: β

Other details

Type of Mutation: Duplication
Ethnic Origin: Ghanaian, African-Canadian
Molecular mechanism: N/A
Inheritance: Recessive
DNA Sequence Determined: Yes

In silico pathogenicity prediction

Publications / Origin

  1. Frischknecht H, Dutly F, A 65 bp duplication/insertion in exon II of the beta globin gene causing beta0-thalassemia., Haematologica , 92(3), 423-4, 2007
  2. Waye JS, Eng B, Hellens L, Hohenadel BA, Nakamura LM, Walker L, Normal Hb A2 β-thalassemia trait: frameshift mutation (HBB: c.187_251dup) in cis with the Hb A2' δ-globin gene missense mutation (HBD: c.49G>C)., Hemoglobin , 37(2), 201-4, 2013
Created on 2013-09-30 17:07:53, Last reviewed on 2022-04-12 16:40:05 (Show full history)

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.